We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

161 hedge funds and large institutions have $713M invested in PharMerica Corporation in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 59

1% less funds holding

Funds holding: 162161 (-1)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

15% less capital invested

Capital invested by funds: $839M → $713M (-$126M)

78% less call options, than puts

Call options by funds: $51K | Put options by funds: $230K

Holders
161
Holders Change
-1
Holders Change %
-0.62%
% of All Funds
4.67%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
59
Reduced
59
Closed
20
Calls
$51K
Puts
$230K
Net Calls
-$179K
Net Calls Change
+$490K
Name Holding Trade Value Shares
Change
Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$7.24M +$1.18M +44,334 +18%
RFC
27
Russell Frank Company
Washington
$6.83M -$1.22M -46,137 -14%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$6.6M +$236K +8,902 +3%
KIM
29
Kestrel Investment Management
California
$6.2M -$10.3M -389,225 -61%
Charles Schwab
30
Charles Schwab
California
$5.93M +$101K +3,807 +2%
Renaissance Technologies
31
Renaissance Technologies
New York
$5.83M -$2.47M -93,069 -28%
Fuller & Thaler Asset Management
32
Fuller & Thaler Asset Management
California
$5.62M +$641K +24,169 +12%
PPA
33
Parametric Portfolio Associates
Washington
$5.5M +$380K +14,343 +7%
Lord, Abbett & Co
34
Lord, Abbett & Co
New Jersey
$5.46M +$5.92M +223,400 New
Millennium Management
35
Millennium Management
New York
$5.34M +$22.3K +840 +0.4%
GAM
36
Gotham Asset Management
New York
$5.23M -$8.74M -329,509 -61%
PAM
37
Panagora Asset Management
Massachusetts
$5.1M -$1.91M -71,927 -26%
AL
38
AJO LP
Pennsylvania
$4.9M +$740K +27,900 +16%
Prudential Financial
39
Prudential Financial
New Jersey
$4.68M -$150K -5,671 -3%
Goldman Sachs
40
Goldman Sachs
New York
$4.46M -$325K -12,273 -6%
Principal Financial Group
41
Principal Financial Group
Iowa
$4.42M -$45.8K -1,728 -0.9%
TCIM
42
TIAA CREF Investment Management
New York
$3.82M -$385K -14,521 -8%
Wells Fargo
43
Wells Fargo
California
$3.67M -$1.61M -60,621 -29%
BCM
44
Bridgeway Capital Management
Texas
$3.6M +$9.28K +350 +0.2%
PCA
45
Personal Capital Advisors
California
$3.47M -$1.54M -58,187 -29%
Connor, Clark & Lunn Investment Management (CC&L)
46
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.45M -$5.3K -200 -0.1%
MAA
47
Managed Account Advisors
New Jersey
$3.4M +$2.04M +76,799 +123%
U
48
UBS
Switzerland
$2.88M +$676K +25,476 +28%
OCG
49
Opus Capital Group
Ohio
$2.85M +$3.1M +116,735 New
BIM
50
BlackRock Investment Management
Delaware
$2.84M +$20.9K +787 +0.7%

PMC Hedge Fund Activity: Q3 2014 in Review

161 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q3 2014, worth a combined $713M — down 15% from $839M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of PMC and 19 opened new positions — a net loss of 1 holder — while 59 trimmed existing stakes and 59 added.

The largest buyer was Ameriprise, adding an estimated $20.8M. The largest seller was Kestrel Investment Management, cutting an estimated $10.3M.

  • 161 institutional investors held PharMerica Corporation (PMC) as of Q3 2014, down from 162 in Q2 2014.
  • Funds reported $713M of PharMerica Corporation stock for Q3 2014, down 15% quarter-over-quarter.
  • 19 funds opened new PharMerica Corporation positions in Q3 2014 and 20 closed out, a net change of -1 holder.
  • The largest PharMerica Corporation buyer in Q3 2014 was Ameriprise, an estimated $20.8M added.
  • The largest PharMerica Corporation seller in Q3 2014 was Kestrel Investment Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q3 2014.